全文获取类型
收费全文 | 266373篇 |
免费 | 20475篇 |
国内免费 | 1148篇 |
专业分类
耳鼻咽喉 | 2892篇 |
儿科学 | 7171篇 |
妇产科学 | 4911篇 |
基础医学 | 35220篇 |
口腔科学 | 5015篇 |
临床医学 | 26925篇 |
内科学 | 56846篇 |
皮肤病学 | 3532篇 |
神经病学 | 25369篇 |
特种医学 | 8981篇 |
外国民族医学 | 11篇 |
外科学 | 40852篇 |
综合类 | 3882篇 |
一般理论 | 327篇 |
预防医学 | 22936篇 |
眼科学 | 6726篇 |
药学 | 18280篇 |
5篇 | |
中国医学 | 366篇 |
肿瘤学 | 17749篇 |
出版年
2023年 | 1273篇 |
2022年 | 2121篇 |
2021年 | 5622篇 |
2020年 | 3395篇 |
2019年 | 5476篇 |
2018年 | 6169篇 |
2017年 | 4639篇 |
2016年 | 5109篇 |
2015年 | 6010篇 |
2014年 | 8908篇 |
2013年 | 12217篇 |
2012年 | 18605篇 |
2011年 | 19522篇 |
2010年 | 10904篇 |
2009年 | 9738篇 |
2008年 | 17205篇 |
2007年 | 18105篇 |
2006年 | 17919篇 |
2005年 | 17919篇 |
2004年 | 16811篇 |
2003年 | 15672篇 |
2002年 | 14673篇 |
2001年 | 2700篇 |
2000年 | 2233篇 |
1999年 | 2863篇 |
1998年 | 3304篇 |
1997年 | 2753篇 |
1996年 | 2400篇 |
1995年 | 2279篇 |
1994年 | 1951篇 |
1993年 | 1757篇 |
1992年 | 1707篇 |
1991年 | 1570篇 |
1990年 | 1419篇 |
1989年 | 1330篇 |
1988年 | 1311篇 |
1987年 | 1257篇 |
1986年 | 1259篇 |
1985年 | 1302篇 |
1984年 | 1479篇 |
1983年 | 1325篇 |
1982年 | 1524篇 |
1981年 | 1478篇 |
1980年 | 1272篇 |
1979年 | 936篇 |
1978年 | 919篇 |
1977年 | 819篇 |
1976年 | 727篇 |
1975年 | 630篇 |
1974年 | 673篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
211.
Ming Zhao Cheng Simon C F Rawlinson Andrew A Pitsillides Gul Zaman Subburaman Mohan David J Baylink Lance E Lanyon 《Journal of bone and mineral research》2002,17(4):593-602
The mechanism by which mechanical strain and estrogen stimulate bone cell proliferation was investigated using monolayer cultures of human osteoblastic TE85 cells and female human primary (first-passage) osteoblasts (fHOBs). Both cell types showed small but statistically significant dose-dependent increases in [3H]thymidine incorporation in response to 17beta-estradiol and to a single 10-minute period of uniaxial cyclic strain (1 Hz). In both cell types, the peak response to 17beta-estradiol occurred at 10(-8) - 10(-7) M and the peak response to strain occurred at 3500 microstrain ((mu)epsilon). Both strain-related and 17beta-estradiol-related increases in [3H]thymidine incorporation were abolished by the estrogen receptor (ER) modulator ICI 182,780 (10-8 M). Tamoxifen (10(-9) - 10(-8) M) increased [3H]thymidine incorporation in both cell types but had no effect on their response to strain. In TE85 cells, tamoxifen reduced the increase in [3H]thymidine incorporation associated with 17beta-estradiol to that of tamoxifen alone but had no such effect in fHOBs. In TE85 cells, strain increased medium concentrations of insulin-like growth factor (IGF) II but not IGF-I, whereas 17beta-estradiol increased medium concentrations of IGF-I but not IGF-II. Neutralizing monoclonal antibody (MNAb) to IGF-I (3 microg/ml) blocked the effects of 17beta-estradiol and exogenous truncated IGF-I (tIGF-I; 50 ng/ml) but not those of strain or tIGF-II (50 ng/ml). Neutralizing antibody to IGF-II (3 microg/ml) blocked the effects of strain and tIGF-II but not those of 17beta-estradiol or tIGF-I. MAb aIR-3 (100 ng/ml) to the IGF-I receptor blocked the effects on [3H]thymidine incorporation of strain, tIGF-II, 17beta-estradiol, and tIGF-I. HOBs and TE85 cells, act similarly to rat primary osteoblasts and ROS 17/2.8 cells in their dose-related proliferative responses to strain and 17beta-estradiol, both of which can be blocked by the ER modulator ICI 182,780. In TE85 cells (as in rat primaries and ROS 17/2.8 cells), the response to 17beta-estradiol is mediated by IGF-I, and the response to strain is mediated by IGF-II. Human cells differ from rat cells in that tamoxifen does not block their response to strain and reduces the response to 17beta-estradiol in TE85s but not primaries. In both human cell types (unlike rat cells) the effects of strain and IGF-II as well as estradiol and IGF-I can be blocked at the IGF-I receptor. 相似文献
212.
213.
214.
215.
216.
217.
218.
219.
Guerard W. Byrne Johannes M. Schirmer David N. Fass Sumeet S. Teotia Walter K. Kremers Hui Xu Bashoo Naziruddin Henry D. Tazelaar John S. Logan Christopher G. A. McGregor 《American journal of transplantation》2005,5(5):1011-1020
Microvascular thrombosis is a prominent feature in cardiac delayed xenograft rejection (DXR). We investigated the impact of warfarin or low-molecular-weight heparin (LMWH) anti-coagulation on xenograft function using a heterotopic pig-to-primate model. Donor hearts were from CD46 transgenic pigs and baboon immunosuppression included tacrolimus, sirolimus, anti-CD20 and TPC, an alpha-galactosyl-polyethylene glycol conjugate. Three groups of animals were studied. Group 1 (n = 9) was treated with warfarin, Group 2 (n = 13) with LMWH and Group 3, received no anti-coagulant drugs. The median duration of xenograft function was 20 days (range 3-62 days), 18 days (range 5-109 days) and 15 days (range 4-53 days) in Groups 1 to 3 respectively. Anti-coagulation achieved the targeted international normalized prothrombin ratio (INR) and anti-factor Xa levels consistent with effective in vivo therapy yet, no significant impact on median xenograft function was observed. At rejection, a similar histology of thrombosis and ischemia was apparent in each group and the levels of fibrin deposition and platelet thrombi in rejected tissue was the same. Anti-coagulation with warfarin or LMWH did not have a significant impact on the onset of DXR and microvascular thrombosis. However, a role for specific anti-coagulant strategies to achieve long-term xenograft function cannot be excluded. 相似文献
220.